MERIDIAN DIAGNOSTICS INC
SC 13G/A, 1996-02-07
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: MERIDIAN DIAGNOSTICS INC, SC 13G/A, 1996-02-07
Next: MERRILL LYNCH GLOBAL BOND FUND FOR INVESTMENT & RETIREMENT, 497, 1996-02-07



<PAGE>



                SECURITIES AND EXCHANGE COMMISSION
                      WASHINGTON, D.C. 20549


                           SCHEDULE 13G


            Under the Securities Exchange Act of 1934
                        (Amendment No. 9)*



                    MERIDIAN DIAGNOSTICS, INC.
        _________________________________________________
                         (Name of Issuer)



                           Common Stock
        _________________________________________________
                  (Title of Class of Securities)



                           589602 10 1
        _________________________________________________
                          (CUSIP Number)

Check the following box if a fee is being paid with this
statement [ ].  (A fee is not required only if the filing person:
(1) has a previous statement on file reporting beneficial
ownership of more than five percent of the class of securities
described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of
such class.)  (See Rule 13d-7.)

*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.

The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).


                 (Continued on following page(s))

                        Page 1 of 4 Pages

<PAGE>


CUSIP NO. 589602 10 1          13G              Page 2 of 4 Pages


  1  NAME OF REPORTING PERSONS
     S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
        
        JERRY L. RUYAN
        ###-##-####


  2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*         (a)   [ ]  

        See Item 4                                              (b)  [X]  

  3  SEC USE ONLY


  4  CITIZENSHIP OR PLACE OF ORGANIZATION
        
        United States of America
        

                 5  SOLE VOTING POWER

                       2,478,668
   NUMBER OF
     SHARES      6  SHARED VOTING POWER
  BENEFICIALLY
    OWNED BY
      EACH             129,846
   REPORTING
  PERSON WITH    7  SOLE DISPOSITIVE POWER
             
                       2,478,668

                 8  SHARED DISPOSITIVE POWER

                       129,846

  9  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
           
          2,608,514

 10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
     SHARES* 

         

 11  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
        
          18.3%

 12  TYPE OF REPORTING PERSON*
        
          IN
        

              *SEE INSTRUCTIONS BEFORE FILLING OUT!


<PAGE>
                                                Page 3 of 4 Pages


ITEM 1(a) Name of Issuer:     Meridian Diagnostics, Inc.

     1(b) Address of Issuer's Principal Executive Office:

          3471 River Hills Drive
          Cincinnati, Ohio  45244

     2(a) Name of Persons Filing:  Jerry L. Ruyan

     2(b) Address of Principal Business Office:

          3471 River Hills Drive
          Cincinnati, Ohio  45244

     2(c) Citizenship:   U.S.A.

     2(d) Title of Class of Securities:

          Common Stock, No Par Value

     2(e) CUSIP No.:     589602 10 1

     3.   If this Statement is Filed Pursuant to Rules 13d-1(b)
          or 13d-2(b), check whether the Person Filing is a:  

          N/A

     4.   Ownership:

          (a)  See Item 9 of cover page.
          (b)  See Item 11 of cover page.
          (c)  See Items 5-8 of cover page.

          This Amendment No. 9 to Schedule 13G is filed solely by
     Jerry L. Ruyan.  The original Schedule 13G and all
     amendments prior to Amendment No. 6 to Schedule 13G were
     filed by Jerry L. Ruyan and William J. Motto on the same
     Schedule 13G.  All shares reported hereunder have been
     adjusted to reflect a three percent stock dividend effective
     December 8, 1994 and a three-for-two stock split effective
     October 2, 1995.

          The shares in Items 5, 7 and 9 include options that are
     exercisable within 60 days into 44,838 shares.  The
     aggregate amount of shares shown in Items 6, 8, and 9 for
     Mr. Ruyan includes 125,765 shares held by Mr. Ruyan as
     trustee of the Ruyan Family Charitable Remainder Unitrust
     and 4,081 shares held as custodian for his son.

          William J. Motto and Jerry L. Ruyan are parties to an
     agreement ("Agreement") with the Company pursuant to which
     they must offer their shares for sale to the Company, and if
     it declines to purchase, to the other signatories at a price
     based on current market prices, if either of them desires to
     sell shares in excess of 1% of the Company's outstanding
     Common Stock in any three-month period.  Mr. Ruyan does not


<PAGE>
                                             Page 4 of 4 Pages   

     affirm that the Agreement operates to make Messrs. Motto and
     Ruyan a group for purposes of Section 13(d)(3) of Securities
     Exchange Act of 1934.  The Agreement previously was filed as
     an Exhibit to Registration Statement No. 33-6052.  The First
     Amendment to the Agreement, which removed Richard H. Walter
     as a party to the Agreement, previously was filed as an
     Exhibit to the Form 10-K of Meridian Diagnostics, Inc. for
     the fiscal year ended September 30, 1992.

     5.   Ownership of 5% or less of class:  N/A

     6.   Ownership of more than 5% on behalf of another person:

          N/A

     7.   Identification and classification of the subsidiary
          which acquired the security being reported by the
          parent holding company:  N/A

     8.   Identification and classification of members of the
          group:    N/A

     9.   Notice of dissolution of group:    N/A

     10.  Certification:      N/A


     After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.



Date:  January 30, 1996            Jerry L. Ruyan
       ________________            _____________________
                                   Jerry L. Ruyan



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission